Article

Adjunctive Use of Oral MAF is Associated with No Disease Progression or Mortality in Hospitalized Patients with COVID-19 Pneumonia: COral-MAF1 Trial

2022-02-22

Abstract excerpt

Since the beginning of the Coronavirus Disease 2019 (COVID-19) outbreak, the scientific community have put considerable efforts to develop and characterize protective measures including vaccines and several treatment strategies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with very promising results. However, taking into account the future fallouts of the new emerging virus variants, poten...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4c09be2f-730e-5638-9dfc-f20458d192dd
DOI: 10.2139/ssrn.4041404

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Adjunctive Use of Oral MAF is Associated with No Disease Progression or Mortality in Hospitalized Patients with COVID-19 Pneumonia: COral-MAF1 TrialDOI 10.2139/ssrn.4041404Read

Efficacy of clarithromycin on COVID-19 pneumonia without oxygen administration; protocol for multicenter, open-label, randomized-controlled, 3-armed parallel group comparison, exploratory trial (CAME COVID study)Semantic proximity Read

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir Vs Currently Used Therapy in Severe COVID-19 Adults. (COMVIVIR, clinicaltrials.gov NCT04475991)Semantic proximity Read

Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.Semantic proximity Read

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trialSemantic proximity Read

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trialSemantic proximity Read

Adjunctive Corticosteroids for COVID-19: A Retrospective Cohort StudySemantic proximity Read

Therapeutic Combinations in Mild or Moderate COVID-19 to Reduce Nasopharyngeal Carriage of SARS-CoV-2 and Prevent Severe COVID-19 in Côte D’Ivoire: A Pragmatic Phase IIb Randomized Controlled Clinical Trial. The ANRS COV01 INTENSE-COV TrialSemantic proximity Read

Molnupiravir, an Oral Antiviral Treatment for COVID-19Semantic proximity Read

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir vs Currently Used Therapy in Severe COVID-19 Adults. “COMVIVIR” Trial.Semantic proximity Read

Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational studySemantic proximity Read